Yunnan Botanee Bio-Tech Group
Launch date
Employees
Market cap
€2.1b
Enterprise valuation
€1.8b (Public information from Sep 2024)
Share price
CNY39.85 300957.SZ
Kunming Yunnan (HQ)
Financials
Estimates*
| CNY | 2019 | 2020 | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|---|---|
| Revenues | 1.9b | 2.6b | 4.0b | 5.0b | 5.5b | 62.5b |
| % growth | - | 36 % | 53 % | 25 % | 10 % | - |
| EBITDA | 583m | 694m | 1.1b | 1.3b | 1.1b | - |
| % EBITDA margin | 30 % | 26 % | 27 % | 27 % | 19 % | - |
| Profit | 412m | 544m | 863m | 1.1b | 757m | - |
| % profit margin | 21 % | 21 % | 21 % | 21 % | 14 % | - |
| R&D budget | 54.1m | 63.4m | 113m | 255m | 299m | - |
| R&D % of revenue | 3 % | 2 % | 3 % | 5 % | 5 % | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
